An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study

By Price David   Haughney John   Lloyd Adam   Hutchinson Julia   Plumb Jonathan  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1671-1679

Informa Healthcare

Access to resources Recommend Favorite

A Health-Related Quality-of-Life Comparison of Formoterol (Oxis^®) Turbuhaler^® plus Budesonide (Pulmicort^®) Turbuhaler^® with Budesonide Turbuhaler^® Alone and Noncorticosteroid Treatment in Asthma: A Randomized Clinical Study in Russia

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 427-433

Karger

Access to resources Recommend Favorite

Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey

By Evans Marc   Jensen Henrik Holm   Bøgelund Mette   Gundgaard Jens   Chubb Barrie   Khunti Kamlesh  

Journal of Medical Economics, Vol. 16, Iss. 11, 2013-11 ,pp. : 1357-1365

Informa Healthcare

Access to resources Recommend Favorite

Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study

By Lundborg Mikael   Wille Sören   Bjermer Leif   Tilling Björn   Lundgren Michael   Telg Gunilla   Ekström Tommy   Selroos Olof  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 809-821

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/formoterol for maintenance and reliever therapy: new quality in asthma management

By Kuna Piotr   Kuprys-Lipinska Izabela  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 495-512

Future Medicine

Access to resources Recommend Favorite